EP0205247A2 — Derivatives of quinuclidine
Assigned to STATE OF ISRAEL REPRESENTED BY PRIME MINISTER'S OFFICE ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH · Expires 1986-12-17 · 39y expired
What this patent protects
Quinuclidine derivatives having the general formula (I) and geometrical isomers, enantiomers, diastereoisomers, racemates and/or acid addition salts thereof, wherein Z represents the group >CR 1 R 2 or two hydrogen atoms; and R 1 and R 2 , which may be identical or diff…
USPTO Abstract
Quinuclidine derivatives having the general formula (I) and geometrical isomers, enantiomers, diastereoisomers, racemates and/or acid addition salts thereof, wherein Z represents the group >CR 1 R 2 or two hydrogen atoms; and R 1 and R 2 , which may be identical or different, are each alkyl, cyclopentyl, cyclohexyl, aryl, or diarylmethylol, or alkyl which is substituted by one or more aryl groups, or one of R 1 and R 2 may be hydrogen.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.